Investor

ILS manager & investor success at matching risk returns vital for market growth: Dubinsky, Gallagher Securities – Go Health Pro

by
ILS manager & investor success at matching risk returns vital for market growth: Dubinsky, Gallagher Securities – Go Health Pro

2024 was another record issuance year for the catastrophe bond market and with total alternative reinsurance capital reaching new heights, the way insurance-linked securities (ILS) managers and investors matched appropriate risk returns was a notable success, according to Bill Dubinsky, Managing Director and CEO of Gallagher Securities.We spoke with Dubinsky, who heads up the capital … Read more

What Is a Squatter? Houston Real Estate Investor Rights Explained – Go Health Pro

by
What Is a Squatter? Houston Real Estate Investor Rights Explained – Go Health Pro

What is a squatter, and why does it matter for you as a real estate investor? When you invest in real estate, protecting your property is essential, especially in a bustling city like Houston. But what happens when someone occupies your property without your permission? This situation can be more than frustrating—it can challenge your … Read more

Meta Must Face Investor Suit After Supreme Court Drops Case – Go Health Pro

by
Meta Must Face Investor Suit After Supreme Court Drops Case – Go Health Pro

The US Supreme Court dismissed an appeal by Meta Platforms Inc., leaving it to face a lawsuit that accuses the company of misleading shareholders about the data-harvesting scandal involving political consulting firm Cambridge Analytica. Investors claim the company, then known as Facebook, inflated share prices by failing to adequately disclose the risk that its user … Read more

Zacks Small Cap Research – OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR – Go Health Pro

by

NASDAQ:GRCE | NASDAQ:ACST Since the recording of this interview, the company has changed its name to Grace Therapeutics and is now trading under NASDAQ:GRCE. John Viglotti: Hello, and welcome to Virtual Investor Conferences. My name’s John Viglotti, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you joined … Read more

Zacks Small Cap Research – OTC Markets Hosts Virtual Investor Presentation with Dror Bashan, President & CEO of Protalix Biotherapeutics, and John Vandermosten, Senior Analyst at Zacks SCR – Go Health Pro

by

NYSE:PLX John Viglotti: Hello, and welcome to Virtual Investor Conferences. My name is John Viglotti, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you joined us for our next presentation from Protalix Biotherapeutics. Their session will be moderated by John Vandermosten. He’s the Senior Biotechnology Analyst with … Read more

x